Hepatic ischemia/reperfusion injury is prevented by a novel matrix metalloproteinase inhibitor, ONO-4817

Surgery

Volumn 139, Issue 5, 2006, Pages 653-664

  Shirahane, Kengo ^a   Yamaguchi, Koji ^a   Koga, Kenichiro ^a   Watanabe, Masato ^a   Kuroki, Syoji ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; ALANINE AMINOTRANSFERASE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CLAMP; CONTROLLED STUDY; DOWN REGULATION; GELATINIZATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEPATIC ARTERY; LIVER CELL; LIVER HISTOLOGY; LIVER ISCHEMIA; MALE; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINASE INHIBITION; RANDOMIZATION; RAT; REPERFUSION INJURY; ZYMOGRAPHY;

ANIMALS; DISEASE MODELS, ANIMAL; DNA PRIMERS; KINETICS; LIVER CIRCULATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; PHENYL ETHERS; RATS; RATS, WISTAR; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646413948     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.10.002     Document Type: Article

References (41)

1. Farhood A., McGuire G.M., Manning A.M., et al. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. Journal of Leukoce Biol 57 (1995) 368-374
2. Lentsch A.B., Yoshidome H., Cheadle W.G., et al. Chemokine involvement in hepatic ischemia/reperfusion injury in mice. Roles for macrophage inflammatory protein-2 and KC. [republished from Hepatology 1998;27:507-12]. Hepatology 27 (1998) 1172-1177
3. Jaeschke H., and Smith C.W. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 61 (1997) 647-653
4. Birkedal-Hansen H., Moore W.G., Bodden M.K., et al. Matrix metalloproteinases. A review. Crit Rev Oral Biol Med 4 (1993) 197-250
5. Soccal P.M., Gasche Y., Pache J.C., et al. Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation 70 (2000) 998-1005
6. Cheung P.Y., Sawicki G., Wozniak M., et al. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101 (2000) 1833-1839
7. Romanic A.M., White R.F., Arleth A.J., et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030
8. Planas A.M., Sole S., Justicia C., et al. Estimation of gelatinase content in rat brain. Effect of focal ischemia. Biochem Biophys Res Commun 278 (2000) 803-807
9. Rosenberg G.A., Estrada E.Y., Dencoff J.E., et al. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier. An expanded therapeutic window. Brain Res 703 (1995) 151-155
10. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
11. Fukuda S., Fini C.A., Mabuchi T., et al. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35 (2004) 998-1004
12. Pfefferkorn T., and Rosenberg G.A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34 (2003) 2025-2030
13. Liotta L.A. Cancer cell invasion and metastasis. Sci Am 266 (1992) 54-59 62-3
14. MacDougall J.R., and Matrisian L.M. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14 (1995) 351-362
15. Jiang W.G., Puntis M.C., and Hallett M.B. Molecular and cellular basis of cancer invasion and metastasis. Implications for treatment. Br J Surg 81 (1994) 1576-1590
16. Folkman J. Angiogenesis in psoriasis. Therapeutic implications. J Invest Dermatol 59 (1972) 40-43
17. Cursio R., Mari B., Louis K., Rostagno P., et al. Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor. Faseb J 16 (2002) 93-95
18. Yamada A., Uegaki A., Nakamura T., et al. ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs. Inflamm Res 49 (2000) 144-146
19. Hariya A., Takazawa K., Yamamoto T., et al. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant. J Heart Lung Transplant 23 (2004) 1163-1169
20. Deryckere F., and Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16 (1994) 405
21. Morrison T.B., Weis J.J., and Wittwer C.T. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24 (1998) 954-958 960, 962
22. Galis Z.S., Sukhova G.K., and Libby P. Microscopic localization of active proteases by in situ zymography. Detection of matrix metalloproteinase activity in vascular tissue. Faseb J 9 (1995) 974-980
23. Knox J.B., Sukhova G.K., Whittemore A.D., et al. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95 (1997) 205-212
24. Mungall B.A., Pollitt C.C., and Collins R. Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography. Histochem Cell Biol 110 (1998) 535-540
25. Krejci-Papa N.C., and Paus R. A novel in situ-zymography technique localizes gelatinolytic activity in human skin to mast cells. Exp Dermatol 7 (1998) 321-326
26. Nakamura H., Ueno H., Yamashita K., et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 59 (1999) 467-473
27. Ikeda M., Maekawa R., Tanaka H., et al. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor. Application of film in situ zymography. Clin Cancer Res 6 (2000) 3290-3296
28. Wang X., Barone F.C., White R.F., et al. Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke. Stroke 29 (1998) 516-520
29. Malinin N.L., Boldin M.P., Kovalenko A.V., et al. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385 (1997) 540-544
30. Bradham C.A., Schemmer P., Stachlewitz R.F., et al. Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg 5 (1999) 282-293
31. Yoshidome H., Kato A., Edwards M.J., et al. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice. Implications of a central role for nuclear factor kappaB. Hepatology 30 (1999) 203-208
32. Takeuchi D., Yoshidome H., Kato A., et al. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology 39 (2004) 699-710
33. Miyagi S., Ohkohchi N., Oikawa K., et al. Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft. Transplantation 77 (2004) 1487-1493
34. Tsuchihashi S., Tamaki T., Tanaka M., et al. Pyrrolidine dithiocarbamate provides protection against hypothermic preservation and transplantation injury in the rat liver. The role of heme oxygenase-1. Surgery 133 (2003) 556-567
35. Muller C., Dunschede F., Koch E., et al. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol 285 (2003) G769-G778
36. Glanemann M., Strenziok R., Kuntze R., et al. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 135 (2004) 203-214
37. Zhong Z., Froh M., Connor H.D., et al. Prevention of hepatic ischemia-reperfusion injury by green tea extract. Am J Physiol Gastrointest Liver Physiol 283 (2002) G957-G964
38. Gearing A.J., Beckett P., Christodoulou M., et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370 (1994) 555-557
39. McGeehan G.M., Becherer J.D., Bast Jr. R.C., et al. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370 (1994) 558-561
40. Naito Y., Takagi T., Kuroda M., et al. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Inflamm Res 53 (2004) 462-468
41. Lee K.S., Jin S.M., Kim H.J., et al. Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 111 (2003) 1278-1284